BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...

BETHLEHEM, Pa., March 23, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that it has submitted to the U.S. Food and Drug Administration ("FDA") an application for a ...

BETHLEHEM — OraSure Technologies and drugmaker AbbVie have agreed to end an agreement under which the companies have been co-promoting OraSure’s OraQuick HCV Rapid Antibody Test in the U.S. The ...

Bethlehem, PA-based OraSure Technologies (NASDAQ:OSUR) has received the FDA's OK for its OraQuick hepatitis C rapid antibody test. It is the the first rapid HCV test approved by the FDA for use in the ...

SILVER SPRING, Md. The Food and Drug Administration has approved a new rapid blood test for detecting hepatitis C, the agency said Friday. The FDA approved Bethlehem, Pa.-based OraSure Technologies’ ...

The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global ...

The Chronic Liver Disease Foundation (CLDF) announced today that it's collaborating with Walgreens to offer free hepatitis C (HCV) testing with the OraQuick® HCV Rapid Test at more than 60 Walgreens ...

In two separate moves, the FDA has approved the first assay to detect both antigen and antibodies to HIV and the first rapid blood test for hepatitis C virus (HCV) antibodies. The Architect HIV Ag/Ab ...

Please provide your email address to receive an email when new articles are posted on . Novel point-of-care hepatitis C tests have advanced the potential for same-day viral diagnosis, which could ...